Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Infection and Chemotherapy
Metadata
Title
Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan
Authors
Kenji Suzuki
Tadao Nishimura
Shunkichi Baba
Publication date
01-03-2003
Publisher
Springer-Verlag
Published in
Journal of Infection and Chemotherapy / Issue 1/2003
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-002-0209-3

Other articles of this Issue 1/2003

Journal of Infection and Chemotherapy 1/2003 Go to the issue

ORIGINAL ARTICLE

Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin

ORIGINAL ARTICLE

Clinical study of Japanese spotted fever and its aggravating factors

ORIGINAL ARTICLE

A case-control study of purple urine bag syndrome in geriatric wards

BRIEF COMMUNICATION

Intrinsic resistance of Escherichia coli to mureidomycin A and C due to expression of the multidrug efflux system AcrAB-TolC: comparison with the efflux systems of mureidomycin-susceptible Pseudomonas aeruginosa

REVIEW ARTICLE

New approaches to developing antimicrobials for resistant bacteria

NOTE

The intraocular dynamics of vancomycin hydrochloride ophthalmic ointment (TN-011) in rabbits

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits